HSDT heliusmedical.com Expected net earnings per share growth this year
The development of Helius Medical (HSDT) is hindered by insurance reimbursement complexities and the prolonged verification of neuromodulation efficacy. The annual earnings per share growth indicator visualizes these cycles, where 11.50 reflects the metric's baseline. PoNS patents and strict FDA oversight serve as business protections, while operations in Western jurisdictions minimize geopolitical risks.
Financial and market metric breakdowns for heliusmedical.com (HSDT)
- market value and analyst target forecast:
- market capitalization data:
- shareholders' equity book value data:
- debt and solvency information:
Debt to Capital Helius Medical|HSDT - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Helius Medical Technologies|HSDT - Company Aggregate Debts|Debts to Net Assets Helius Medical Technologies, Inc.|HSDT - Company Long-Term Debts|Company Current Liabilities Helius Medical Technologies|Quick Ratio heliusmedical.com
- net income and valuation multiples indicators:
HSDT - Company Net Income|Expected Profit Helius Medical|HSDT - P/E Multiple|Future Price to Earnings Multiple Helius Medical Technologies|HSDT - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Helius Medical Technologies, Inc.|HSDT - Operating profit EBITDA|Earnings per share for the last 12 months Helius Medical Technologies|HSDT - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months heliusmedical.com|HSDT - Earnings per share growth in current year|Projected earnings per share growth rate for next year Helius Medical
Fundamental valuation:HSDT - Helius Medical Technologies Inc.
This indicator reflects the year-over-year dynamics of net earnings per share relative to the business's operational successes. The metric measures the growth or decline rates of return on equity, allowing for an assessment of the issuer's financial stability. For Helius Medical (HSDT), this figure depends directly on the commercialization of brain stimulation devices and the volume of insurance reimbursements. By analyzing the distribution of the annual change in earnings per share, an investor determines the effectiveness of device implementation within clinics. A positive trend confirms the scaling of the biotech model.
Direct competitors
Biogen Inc (BIIB) - Earnings growth in current year|Earnings per share growth in current year Neurocrine Biosciences Inc|Regencell Corp (RGC) - Expected net earnings per share growth this year|Net earnings per share growth this year AXSM (Axsome Therapeutics)|ACAD (acadia-pharm.com) - Earnings per share increase in current year|Earnings per share growth in current year Xenon XENE|VKTX - Net earnings per share growth this year|Supernus Pharma - Earnings growth in current year|Earnings per share growth rate in current year Catalyst Corp|DNLI: Earnings growth in current year|Earnings per share growth this year HRMY|BHVN (Biohaven) - Earnings growth in current year|Amylyx Pharmaceuticals Inc (AMLX) - Expected net earnings per share growth this year|Earnings growth in current year TRVI|Net earnings per share growth this year Praxis Corp PRAX|Earnings growth in current year AVXL (Anavex Life Sciences)|Earnings growth in current year ceribell.com CBLL|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|ANNX: Earnings growth in current year|Omeros - Earnings per share increase in current year|Earnings per share growth in current year Neurogene Inc.|acimmune.com (ACIU) - Expected net earnings per share growth this year|Earnings growth in current year VYGR|Neumora - Earnings per share growth this year|Scilex Holding Co. - Net earnings per share growth this year|Net earnings per one share growth for the current year TVGN (Tevogen Bio Inc.)|ACOG - Earnings per share growth in current year|CGTX (Cognition Therapeutics Inc.) - Earnings per share growth this year|IKT: Earnings growth in current year|Earnings per share growth rate in current year Cassava Sciences Inc (SAVA)|Net earnings per share growth this year ASRT|Earnings growth in current year Coya|Earnings per share growth in current year Vistagen Therapeutics (VTGN)|OVID (ovidrx.com) - Earnings per share increase in current year|Earnings per share growth in current year Acumen Pharmaceuticals, Inc. ABOS|CervoMed, Inc. (CRVO) - Earnings per share growth rate in current year|Alterity Therapeutics Ltd - Earnings growth in current year|Earnings per share increase in current year CLNN (Clene Inc.)|PEPG: Earnings growth in current year|Earnings per share growth rate in current year Jupiter Neurosciences, Inc. (JUNS)|Earnings per share growth in current year Relmada Therapeutics, Inc.|Earnings per share growth in current year ANVS|Earnings growth in current year GRCE|Expected net earnings per share growth this year Firefly Neuro|Klotho Neurosciences - Net earnings per share growth this year|Earnings growth in current year NeuroSense Therapeutics Ltd NRSN|RVPH - Earnings per share growth in current year|Expected net earnings per share growth this year MetaVia Inc MTVA|NRXS (NeurAxis, Inc) - Net earnings per share growth this year|Passage Bio - Earnings per share increase in current year|Earnings per share growth in current year Neuphoria Therapeutics, Inc.|Net earnings per share growth this year minervaneurosciences.com (NERV)|Earnings growth in current year ATHA|ADXN - Earnings per share growth rate in current year|Earnings growth in current year ALZN (Alzamend Neuro)|CYCN: Earnings per share growth this year|Protagenic - Earnings growth in current year|Expected net earnings per share growth this year Pasithea Therapeutics KTTA|CRGT: Earnings growth in current year|Net earnings per share growth this year Avenue Therapeutics Inc.|BCLI (Brainstorm Cell Therapeutics, Inc.) - Earnings growth in current year|Earnings growth in current year Cara Therapeutics Inc|Earnings per share growth in current year Chromocell Therapeutics (CHRO)|Earnings per share growth in current year ELYM (eliemtx.com)|Earnings growth in current year ITCI (Intra-Cellular Therapies, Inc.)|Earnings per share increase in current year LBPH|MRNS - Earnings per share growth in current year|Expected net earnings per share growth this year NKGen Biotech Corp NKGN|NRBO: Earnings growth in current year|Earnings per share growth this year SAGE|Net earnings per share growth this year SNPX|TRVN (Trevena Inc.) - Net earnings per one share growth for the current year|Earnings per share growth in current year Vigil Neuroscience (VIGL)|anewmeds.com - Earnings per share growth this year|Earnings growth in current year CERE (Cerevel Therapeutics)
